{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T11:00:57Z","timestamp":1780052457727,"version":"3.53.1"},"reference-count":43,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,7]],"date-time":"2024-03-07T00:00:00Z","timestamp":1709769600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","ejves.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Vascular and Endovascular Surgery"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.ejvs.2024.02.043","type":"journal-article","created":{"date-parts":[[2024,3,4]],"date-time":"2024-03-04T07:22:33Z","timestamp":1709536953000},"page":"923-932","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["The BioMimics 3D Helical Centreline Nitinol Stent in Chronic Limb Threatening Ischaemia and Complex Lesions: Three Year Outcomes of the MIMICS-3D Registry"],"prefix":"10.1016","volume":"67","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3468-9945","authenticated-orcid":false,"given":"Christos","family":"Rammos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Zeller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4168-1709","authenticated-orcid":false,"given":"Michael","family":"Piorkowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koen","family":"Deloose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Hertting","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Volker","family":"Sesselmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunnar","family":"Tepe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5248-8808","authenticated-orcid":false,"given":"Peter","family":"Gaines","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Lichtenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejvs.2024.02.043_bib1","article-title":"Peripheral artery disease in Germany (2009\u20132018): Prevalence, frequency of specialized ambulatory care and use of guideline-recommended therapy \u2013 a population-based study","volume":"5","author":"Rammos","year":"2021","journal-title":"Lancet Reg Health Eur"},{"key":"10.1016\/j.ejvs.2024.02.043_bib2","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/j.jvs.2022.12.015","article-title":"The global burden of peripheral artery disease","volume":"77","author":"Eid","year":"2023","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.ejvs.2024.02.043_bib3","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.jacbts.2021.04.008","article-title":"Macrophage polarization as a novel therapeutic target for endovascular intervention in peripheral artery disease","volume":"6","author":"Tan","year":"2021","journal-title":"JACC Basic Transl Sci"},{"key":"10.1016\/j.ejvs.2024.02.043_bib4","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1093\/eurheartj\/ehx095","volume":"39","author":"Aboyans","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ejvs.2024.02.043_bib5","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.118.005273","article-title":"Endovascular-first treatment is associated with improved amputation-free survival in patients with critical limb ischemia","volume":"12","author":"Lin","year":"2019","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.ejvs.2024.02.043_bib6","doi-asserted-by":"crossref","first-page":"9","DOI":"10.23736\/S0392-9590.22.04959-8","article-title":"Real-world outcomes of Cook Zilver PTX in femoro-popliteal district from multicenter experience","volume":"42","author":"Bianchini Massoni","year":"2023","journal-title":"Int Angiol"},{"key":"10.1016\/j.ejvs.2024.02.043_bib7","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1161\/CIRCULATIONAHA.115.018034","article-title":"Drug-eluting stents are the default strategy for superficial femoral artery intervention now","volume":"133","author":"Burket","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.ejvs.2024.02.043_bib8","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.5551\/jat.63225","article-title":"Ten-year clinical follow-up following bare-nitinol stent implantation for femoropopliteal artery disease","volume":"29","author":"Soga","year":"2022","journal-title":"J\u00a0Atheroscler Thromb"},{"key":"10.1016\/j.ejvs.2024.02.043_bib9","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1002\/ccd.29777","article-title":"Directional atherectomy before paclitaxel coated balloon angioplasty in complex femoropopliteal disease: the VIVA REALITY study","volume":"98","author":"Rocha-Singh","year":"2021","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.ejvs.2024.02.043_bib10","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.jcin.2018.12.004","article-title":"Drug-coated balloon treatment for femoropopliteal artery disease: the chronic total occlusion cohort in the IN.PACT Global Study","volume":"12","author":"Tepe","year":"2019","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.ejvs.2024.02.043_bib11","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.jmbbm.2017.07.017","article-title":"Comparison of femoropopliteal artery stents under axial and radial compression, axial tension, bending, and torsion deformations","volume":"75","author":"Maleckis","year":"2017","journal-title":"J\u00a0Mech Behav Biomed Mater"},{"key":"10.1016\/j.ejvs.2024.02.043_bib12","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.jvs.2013.03.052","article-title":"Design considerations for studies of the biomechanical environment of the femoropopliteal arteries","volume":"58","author":"Ansari","year":"2013","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.ejvs.2024.02.043_bib13","article-title":"Swirling flow and wall shear: Evaluating the BioMimics 3D helical centerline stent for the femoropopliteal segment","volume":"2018","author":"Sullivan","year":"2018","journal-title":"Int J Vasc Med"},{"key":"10.1016\/j.ejvs.2024.02.043_bib14","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.115.002930","article-title":"Helical centerline stent improves patency: two-year results from the randomized Mimics trial","volume":"9","author":"Zeller","year":"2016","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.ejvs.2024.02.043_bib15","first-page":"126","article-title":"BioMimics 3D stent in femoropopliteal lesions: 3-year outcomes with propensity matching for drug-coated balloons","volume":"10","author":"Piorkowski","year":"2023","journal-title":"J\u00a0Cardiovasc Dev Dis"},{"key":"10.1016\/j.ejvs.2024.02.043_bib16","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1024\/0301-1526\/a000980","article-title":"BioMimics 3D vascular stent system for femoropopliteal interventions","volume":"51","author":"Lichtenberg","year":"2022","journal-title":"Vasa"},{"key":"10.1016\/j.ejvs.2024.02.043_bib17","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1177\/1526602816656612","article-title":"Impact of calcification on clinical outcomes after endovascular therapy for superficial femoral artery disease: assessment using the peripheral artery calcification scoring system","volume":"23","author":"Okuno","year":"2016","journal-title":"J\u00a0Endovasc Ther"},{"key":"10.1016\/j.ejvs.2024.02.043_bib18","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1016\/S0140-6736(23)00462-2","volume":"401","author":"Bradbury","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.ejvs.2024.02.043_bib19","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1056\/NEJMoa2207899","article-title":"Surgery or endovascular therapy for chronic limb-threatening ischemia","volume":"387","author":"Farber","year":"2022","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ejvs.2024.02.043_bib20","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.avsg.2022.04.052","article-title":"Predictors of amputation-free survival after endovascular intervention for chronic limb-threatening ischemia in the modern era","volume":"86","author":"Joshi","year":"2022","journal-title":"Ann Vasc Surg"},{"key":"10.1016\/j.ejvs.2024.02.043_bib21","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/ccd.27635","article-title":"SCAI consensus guidelines for device selection in femoral-popliteal arterial interventions","volume":"92","author":"Feldman","year":"2018","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.ejvs.2024.02.043_bib22","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1016\/j.jvs.2015.01.030","article-title":"Stenting of femoropopliteal lesions using interwoven nitinol stents","volume":"61","author":"Brescia","year":"2015","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.ejvs.2024.02.043_bib23","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1024\/0301-1526\/a000963","article-title":"The impact of percutaneous peripheral interventions on endothelial function","volume":"50","author":"Rammos","year":"2021","journal-title":"Vasa"},{"key":"10.1016\/j.ejvs.2024.02.043_bib24","doi-asserted-by":"crossref","DOI":"10.1098\/rsif.2013.0578","article-title":"Intimal hyperplasia following implantation of helical-centreline and straight-centreline stents in common carotid arteries in healthy pigs: influence of intraluminal flow","volume":"10","author":"Caro","year":"2013","journal-title":"J\u00a0R Soc Interface"},{"key":"10.1016\/j.ejvs.2024.02.043_bib25","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1161\/01.CIR.0000066914.95878.6D","article-title":"Augmentation of wall shear stress inhibits neointimal hyperplasia after stent implantation: inhibition through reduction of inflammation?","volume":"107","author":"Carlier","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.ejvs.2024.02.043_bib26","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1080\/00015458.2022.2072457","article-title":"Self-expanding interwoven nitinol stent in severe femoropopliteal arterial disease. Real life results of the Supera Peripheral Stent System\u00ae","volume":"123","author":"Van Meirvenne","year":"2023","journal-title":"Acta Chir Belg"},{"key":"10.1016\/j.ejvs.2024.02.043_bib27","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1177\/00033197211043406","article-title":"Analysis of interwoven nitinol stenting for the treatment of critical limb ischemia: outcomes from an average 3-year follow-up period","volume":"73","author":"Krishnan","year":"2022","journal-title":"Angiology"},{"key":"10.1016\/j.ejvs.2024.02.043_bib28","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1177\/15266028211049339","article-title":"Clinical outcome of drug-eluted stenting (Zilver PTX) in patients with femoropopliteal occlusive disease a single center experience","volume":"29","author":"AbuRahma","year":"2022","journal-title":"J\u00a0Endovasc Ther"},{"key":"10.1016\/j.ejvs.2024.02.043_bib29","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1177\/1358863X20987894","article-title":"Outcomes of the paclitaxel-eluting Eluvia stent for long femoropopliteal lesions in Asian patients with predominantly chronic limb-threatening ischemia","volume":"26","author":"Kum","year":"2021","journal-title":"Vasc Med"},{"key":"10.1016\/j.ejvs.2024.02.043_bib30","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1080\/14779072.2019.1675512","article-title":"Newly approved devices for endovascular treatment of femoropopliteal disease: a review of clinical evidence","volume":"17","author":"Giannopoulos","year":"2019","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"10.1016\/j.ejvs.2024.02.043_bib31","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1177\/1526602819860124","article-title":"Vessel calcification as a risk factor for in-stent restenosis in complex femoropopliteal lesions after Zilver PTX paclitaxel-coated stent placement","volume":"26","author":"Ichihashi","year":"2019","journal-title":"J\u00a0Endovasc Ther"},{"key":"10.1016\/j.ejvs.2024.02.043_bib32","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1024\/0301-1526\/a000671","article-title":"Treatment of femoropopliteal lesions with the AngioSculpt scoring balloon \u2013 results from the Heidelberg PANTHER registry","volume":"47","author":"Lugenbiel","year":"2018","journal-title":"Vasa"},{"key":"10.1016\/j.ejvs.2024.02.043_bib33","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1177\/1526602819836095","article-title":"Lumen gain after endovascular therapy in calcified superficial femoral artery occlusive disease assessed by intravascular ultrasound (CODE Study)","volume":"26","author":"Fujihara","year":"2019","journal-title":"J\u00a0Endovasc Ther"},{"key":"10.1016\/j.ejvs.2024.02.043_bib34","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1177\/1526602820915244","article-title":"Two-year outcomes of orbital atherectomy combined with drug-coated balloon angioplasty for treatment of heavily calcified femoropopliteal lesions","volume":"27","author":"Kokkinidis","year":"2020","journal-title":"J\u00a0Endovasc Ther"},{"key":"10.1016\/j.ejvs.2024.02.043_bib35","author":"Horie","year":"2022","journal-title":"J\u00a0Endovasc Ther"},{"key":"10.1016\/j.ejvs.2024.02.043_bib36","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s00270-020-02663-7","article-title":"Paclitaxel-coated balloon angioplasty for the treatment of infrainguinal arteries: 24-month outcomes in the full cohort of BIOLUX P-III global registry","volume":"44","author":"Tepe","year":"2021","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.ejvs.2024.02.043_bib37","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1016\/j.jvs.2019.08.284","article-title":"A\u00a0midterm analysis of patients who received femoropopliteal helical interwoven nitinol stents","volume":"71","author":"Chan","year":"2020","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.ejvs.2024.02.043_bib38","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1177\/1526602820952413","article-title":"Combining the Passeo-18 Lux drug-coated balloon and the Pulsar-18 bare metal stent: 12- and 24-month outcomes of the BIOLUX 4EVER investigator-initiated trial","volume":"27","author":"Deloose","year":"2020","journal-title":"J\u00a0Endovasc Ther"},{"key":"10.1016\/j.ejvs.2024.02.043_bib39","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1002\/ccd.23064","article-title":"Timing of the restenosis following nitinol stenting in the superficial femoral artery and the factors associated with early and late restenoses","volume":"78","author":"Iida","year":"2011","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.ejvs.2024.02.043_bib40","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.jcin.2022.01.019","article-title":"1-Year outcomes of fluoropolymer-based drug-eluting stent in femoropopliteal practice: predictors of restenosis and aneurysmal degeneration","volume":"15","author":"Iida","year":"2022","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.ejvs.2024.02.043_bib41","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.jcin.2021.01.026","article-title":"2-Year outcomes of the Eluvia drug-eluting stent for the treatment of complex femoropopliteal lesions","volume":"14","author":"Stavroulakis","year":"2021","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.ejvs.2024.02.043_bib42","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.ejvs.2022.05.046","article-title":"Drug eluting versus covered stent for femoropopliteal artery lesions: results of the ULTIMATE study","volume":"64","author":"Ichihashi","year":"2022","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.ejvs.2024.02.043_bib43","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1177\/1526602816666261","article-title":"Comparable 2-year restenosis rates following subintimal and intraluminal drug-eluting stent implantation for femoropopliteal chronic total occlusion","volume":"23","author":"Ishihara","year":"2016","journal-title":"J\u00a0Endovasc Ther"}],"container-title":["European Journal of Vascular and Endovascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S107858842400203X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S107858842400203X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,8]],"date-time":"2024-06-08T04:01:51Z","timestamp":1717819311000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S107858842400203X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":43,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S107858842400203X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejvs.2024.02.043","relation":{},"ISSN":["1078-5884"],"issn-type":[{"value":"1078-5884","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The BioMimics 3D Helical Centreline Nitinol Stent in Chronic Limb Threatening Ischaemia and Complex Lesions: Three Year Outcomes of the MIMICS-3D Registry","name":"articletitle","label":"Article Title"},{"value":"European Journal of Vascular and Endovascular Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejvs.2024.02.043","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V. on behalf of European Society for Vascular Surgery.","name":"copyright","label":"Copyright"}]}}